Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

An analysis of adaptations to multi-level intervention strategies to enhance implementation of clinical practice guidelines for treating tobacco use in dental care settings.

Shelley DR, Kyriakos C, Campo A, Li Y, Khalife D, Ostroff J.

Contemp Clin Trials Commun. 2018 Jul 25;11:142-148. doi: 10.1016/j.conctc.2018.07.003. eCollection 2018 Sep.

2.

Smoking-Cessation Interventions for Urban Hospital Patients: A Randomized Comparative Effectiveness Trial.

Sherman SE, Link AR, Rogers ES, Krebs P, Ladapo JA, Shelley DR, Fang Y, Wang B, Grossman E.

Am J Prev Med. 2016 Oct;51(4):566-77. doi: 10.1016/j.amepre.2016.06.023.

3.

Testing the use of practice facilitation in a cluster randomized stepped-wedge design trial to improve adherence to cardiovascular disease prevention guidelines: HealthyHearts NYC.

Shelley DR, Ogedegbe G, Anane S, Wu WY, Goldfeld K, Gold HT, Kaplan S, Berry C.

Implement Sci. 2016 Jul 4;11(1):88. doi: 10.1186/s13012-016-0450-2.

4.

Readiness of Lung Cancer Screening Sites to Deliver Smoking Cessation Treatment: Current Practices, Organizational Priority, and Perceived Barriers.

Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI.

Nicotine Tob Res. 2016 May;18(5):1067-75. doi: 10.1093/ntr/ntv177. Epub 2015 Sep 7.

5.

An Exploration of Online Behaviors and Social Media Use Among Hookah and Electronic-Cigarette Users.

Link AR, Cawkwell PB, Shelley DR, Sherman SE.

Addict Behav Rep. 2015 Dec 1;2:37-40.

6.

Dentists' self-perceived role in offering tobacco cessation services: results from a nationally representative survey, United States, 2010-2011.

Jannat-Khah DP, McNeely J, Pereyra MR, Parish C, Pollack HA, Ostroff J, Metsch L, Shelley DR.

Prev Chronic Dis. 2014 Nov 6;11:E196. doi: 10.5888/pcd11.140186.

8.

What's in a setting?: Influence of organizational culture on provider adherence to clinical guidelines for treating tobacco use.

Hung DY, Leidig R, Shelley DR.

Health Care Manage Rev. 2014 Apr-Jun;39(2):154-63. doi: 10.1097/HMR.0b013e3182914d11.

PMID:
23636103
9.
10.

Assessing the impact of behavioral risk factors and known-groups validity of the SF-12 in a US Chinese immigrant population.

Hung DY, Lubetkin EI, Fahs MC, Shelley DR.

Med Care. 2009 Feb;47(2):262-7. doi: 10.1097/MLR.0b013e3181844de4.

11.

Multilevel analysis of the chronic care model and 5A services for treating tobacco use in urban primary care clinics.

Hung DY, Shelley DR.

Health Serv Res. 2009 Feb;44(1):103-27. doi: 10.1111/j.1475-6773.2008.00896.x. Epub 2008 Sep 8.

12.

Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.

Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T.

Diabetes. 1992 Oct;41(10):1257-66.

PMID:
1397698
13.

Polycystic ovary syndrome.

Shelley DR, Dunaif A.

Compr Ther. 1990 Nov;16(11):26-34. Review.

PMID:
2269012

Supplemental Content

Loading ...
Support Center